345 related articles for article (PubMed ID: 26966035)
21. Pituitary imaging is indicated for the evaluation of hyperprolactinemia.
Bayrak A; Saadat P; Mor E; Chong L; Paulson RJ; Sokol RZ
Fertil Steril; 2005 Jul; 84(1):181-5. PubMed ID: 16009175
[TBL] [Abstract][Full Text] [Related]
22. Primary Hypothyroidism with Exceptionally High Prolactin-A Really Big Deal.
Khorassanizadeh R; Sundaresh V; Levine SN
World Neurosurg; 2016 Jul; 91():675.e11-4. PubMed ID: 27155380
[TBL] [Abstract][Full Text] [Related]
23. [Macroprolactinemia associated with pituitary macroadenoma: treatment with quinagolide].
Lakatos G; Szücs N; Kender Z; Czirják S; Rácz K
Orv Hetil; 2010 Jun; 151(26):1072-5. PubMed ID: 20558354
[TBL] [Abstract][Full Text] [Related]
24. Challenges and pitfalls in the diagnosis of hyperprolactinemia.
Vilar L; Fleseriu M; Bronstein MD
Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):9-22. PubMed ID: 24728159
[TBL] [Abstract][Full Text] [Related]
25. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
[TBL] [Abstract][Full Text] [Related]
26. [Hyperprolactinemia unrelated to prolactinoma].
Krysiak R; Okopień B
Wiad Lek; 2014; 67(2 Pt 1):101-11. PubMed ID: 25764785
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and reproductive manifestations of macroprolactinemia.
Kalsi AK; Halder A; Jain M; Chaturvedi PK; Sharma JB
Endocrine; 2019 Feb; 63(2):332-340. PubMed ID: 30269265
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic pitfalls of hyperprolactinemia: the importance of sequential pituitary imaging.
Kawaguchi T; Ogawa Y; Tominaga T
BMC Res Notes; 2014 Aug; 7():555. PubMed ID: 25142896
[TBL] [Abstract][Full Text] [Related]
29. [Hyperprolactinemia].
König MP; Kopp P
Schweiz Med Wochenschr; 1986 Mar; 116(9):265-70. PubMed ID: 3952483
[TBL] [Abstract][Full Text] [Related]
30. [Prolactin and its receptor: From animal models to pituitary pathophysiology].
Begon E; Bernard V
Biol Aujourdhui; 2022; 216(3-4):105-110. PubMed ID: 36744975
[TBL] [Abstract][Full Text] [Related]
31. Cushing's disease and hyperprolactinemia due to a mixed ACTH- and prolactin-secreting pituitary macroadenoma.
Mahler C; Verhelst J; Klaes R; Trouillas J
Pathol Res Pract; 1991 Jun; 187(5):598-602. PubMed ID: 1656408
[TBL] [Abstract][Full Text] [Related]
32. [Influence of hyperprolactinemia and tumoral size in the postoperative pituitary function in clinically nonfunctioning pituitary macroadenomas].
Fonseca AL; Chimelli L; Santos MJ; Santos AA; Violante AH
Arq Neuropsiquiatr; 2002 Sep; 60(3-A):590-602. PubMed ID: 12244397
[TBL] [Abstract][Full Text] [Related]
33. [Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia].
Vilar L; Moura E; Canadas V; Gusmão A; Campos R; Leal E; Teixeira L; Santos V; Gomes B; Lima M; Paiva R; Albuquerque JL; Egito CS; Botelho CA; Azevedo M; Casulari LA; Naves LA
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):86-91. PubMed ID: 17435860
[TBL] [Abstract][Full Text] [Related]
34. Excessively high prolactin level in a patient with a nonprolactin-secreting adenoma. Case report.
Albuquerque FC; Hinton DR; Weiss MH
J Neurosurg; 1998 Dec; 89(6):1043-6. PubMed ID: 9833836
[TBL] [Abstract][Full Text] [Related]
35. The importance of macroprolactinemia in the differential diagnosis of hyperprolactinemic patients.
Bağdatoğlu C; Bağdatoğlu OT; Muslu N; Köseoğlu A; Dağtekin A; Polat G; Dolgun H; Karataş MA
Turk Neurosurg; 2008 Jul; 18(3):223-7. PubMed ID: 18814107
[TBL] [Abstract][Full Text] [Related]
36. Pituitary adenoma associated with gigantism and hyperprolactinemia.
Alikasifoglu A; Kandemir N; Akalan N; Yordam N
Pediatr Neurosurg; 2001 Dec; 35(6):325-8. PubMed ID: 11786701
[TBL] [Abstract][Full Text] [Related]
37. Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia.
Espinós JJ; Vanrell C; Gich I; Urgell E; Calaf J
Gynecol Endocrinol; 2017 Feb; 33(2):148-151. PubMed ID: 27841032
[TBL] [Abstract][Full Text] [Related]
38. The diagnostic importance of prolactin subgroups in patients with stalk mass.
Bagdatoglu C; Ay A; Bagdatoglu OT; Ozer C; Polat G; Koksel T
Acta Neurochir (Wien); 2005 Feb; 147(2):209-10. PubMed ID: 15647889
[TBL] [Abstract][Full Text] [Related]
39. The value of pituitary magnetic resonance imaging in men with hypogonadism.
Rhoden EL; Estrada C; Levine L; Morgentaler A
J Urol; 2003 Sep; 170(3):795-8. PubMed ID: 12913700
[TBL] [Abstract][Full Text] [Related]
40. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas.
Arafah BM; Prunty D; Ybarra J; Hlavin ML; Selman WR
J Clin Endocrinol Metab; 2000 May; 85(5):1789-93. PubMed ID: 10843153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]